Zobrazeno 1 - 10
of 97
pro vyhledávání: '"A. Onyenadum"'
Autor:
Aravantinos, Gerasimos, Fountzilas, George, Bamias, Aristotelis, Grimani, Irene, Rizos, Spyridon, Kalofonos, Haralabos P., Skarlos, Dimosthenis V., Economopoulos, Theofanis, Kosmidis, Paris A., Stathopoulos, George P., Briasoulis, Evangelos, Pectasides, Dimitrios, Samantas, Epaminondas, Timotheadou, Eleni, Papadimitriou, Christos, Papanikolaou, Alexandros, Onyenadum, Adimchi, Papakostas, Pavlos, Bafaloukos, Dimitrios, Dimopoulos, Meletios A.
Publikováno v:
In European Journal of Cancer 2008 44(15):2169-2177
Autor:
Iconomou, G., Viha, A., Koutras, A., Koukourikou, I., Mega, V., Makatsoris, T., Onyenadum, A., Assimakopoulos, K., Vagenakis, A.G., Kalofonos, H.P. *
Publikováno v:
In Annals of Oncology March 2006 17(3):515-520
Autor:
Xiros, N. *, Papacostas, P., Economopoulos, T., Samelis, G., Efstathiou, E., Kastritis, E., Kalofonos, H., Onyenadum, A., Skarlos, D., Bamias, A., Gogas, H., Bafaloukos, D., Samantas, E., Kosmidis, P.
Publikováno v:
In Annals of Oncology May 2005 16(5):773-779
Autor:
Gogas, H. *, Papadimitriou, C., Kalofonos, H.P., Bafaloukos, D., Fountzilas, G., Tsavdaridis, D., Anagnostopoulos, A., Onyenadum, A., Papakostas, P., Economopoulos, T., Christodoulou, C., Kosmidis, P., Markopoulos, C.
Publikováno v:
In Annals of Oncology November 2002 13(11):1737-1742
Autor:
Dimitrios Bafaloukos, A. Onyenadum, Dimosthenis Skarlos, George P. Stathopoulos, Eleni Timotheadou, Paris Kosmidis, Alexandros Papanikolaou, Evangelos Briasoulis, Christos Papadimitriou, Haralabos P. Kalofonos, Irene Grimani, Aristotelis Bamias, Pavlos Papakostas, Epaminondas Samantas, Spyridon Rizos, Gerasimos Aravantinos, Dimitrios Pectasides, George Fountzilas, Meletios A. Dimopoulos, Theofanis Economopoulos
Publikováno v:
European Journal of Cancer. 44:2169-2177
Introduction: The combination of Carboplatin and Paclitaxel is considered the standard of care as initial chemotherapy for Advanced Ovarian Cancer (AOC). We compared this regimen with the combination of Cisplatin, Paclitaxel and Doxorubicin. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::472089fc6de8c1b6c89cd074a277df18
https://doi.org/10.1016/j.ejca.2008.06.035
https://doi.org/10.1016/j.ejca.2008.06.035
Autor:
A. Onyenadum, I. Koukourikou, Konstantinos Assimakopoulos, Haralabos P. Kalofonos, V. Mega, Thomas Makatsoris, Angelos Koutras, Gregoris Iconomou, Apostolos G. Vagenakis, A. Viha
Publikováno v:
Annals of Oncology. 17:515-520
Background There has been limited research examining the efficacy of providing written information to cancer patients in southern and eastern European countries. This study investigated the impact of a booklet about chemotherapy on patient satisfacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03e8e226527e32b92e82442b25477263
https://doi.org/10.1093/annonc/mdj098
https://doi.org/10.1093/annonc/mdj098
Autor:
Thomas Makatsoris, Fotini Paliogianni, G. Kopsida, H. P. Kalofonos, Angelos Koutras, Athanasia Mouzaki, Charalambos Gogos, A. Onyenadum
Publikováno v:
Oncology. 67:179-182
Background: Oxaliplatin is a novel platinum derivative with established anti-tumor activity in colorectal cancer. Acute-onset hemolytic anemia and thrombocytopenia associated with this drug have rarely been reported and some of these cases have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc48a99a76ad3c8f7a143fe1f97b2627
https://doi.org/10.1159/000081006
https://doi.org/10.1159/000081006
Autor:
Sofia Rokana, Dimitris Dimitropoulos, Niki Stavroyianni, Thomas Makatsoris, A. Onyenadum, Christos Kosmas, Evangelos Sepsas, Maria Vadiaka, Haralambos P. Kalofonos, Nicolas Tsavaris
Publikováno v:
International Journal of Cancer. 98:141-147
In an attempt to develop more effective chemotherapy regimens in advanced nonsmall cell lung cancer (NSCLC), we evaluated docetaxel-ifosfamide-cisplatin (DIP) based on our previous experience with paclitaxel-ifosfamide-cisplatin. Patients with advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee980975937da465c83928d076fb92c0
https://doi.org/10.1002/ijc.10162
https://doi.org/10.1002/ijc.10162
Autor:
C. Bacoyiannis, M.A. Dimopoulos, H.P. Kalofonos, C. Nicolaides, G. Aravantinos, D. Bafaloukos, G. Samelis, A. Onyenadum, Ch. Kiamouris, D. Skarlos, N. Pavlidis, A. Triantafillidis, P. Kosmidis, o on behalf of the Hellenic Cooperative Oncology Group (HeCOG)
Publikováno v:
Oncology. 63:130-138
Background: The aim of this study is firstly to determine the response rates and toxicity of two regimens containing vinblastine (VBL) in combination with interferon-gamma (IFN-γ) in the treatment of patients with advanced renal cell carcinoma (RCC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25e04ee2c856c9a854205df2d1a0fa91
https://doi.org/10.1159/000063806
https://doi.org/10.1159/000063806
Autor:
Haralambos P. Kalofonos, Christos Kosmas, Sofia Rokana, Nicolas Tsavaris, Niki Stavroyianni, Angelos Koutras, Nikolaos A. Malamos, A. Onyenadum, Maria Vadiaka, Aristidis Polyzos
Publikováno v:
Cancer. 92:2902-2910
BACKGROUND Treatment options for patients with recurrent nonsmall cell lung carcinoma (NSCLC) remain limited as a result of poor activity of older agents after platinum-based therapy. In the current Phase II study, the authors evaluated the combinati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f4385b76321c96a18c64f0aae7d35e
https://doi.org/10.1002/1097-0142(20011201)92:11<2902::aid-cncr10103>3.0.co
https://doi.org/10.1002/1097-0142(20011201)92:11<2902::aid-cncr10103>3.0.co